AfaPhos1
AfaPhos1 is a novel Afatinib-based EGFRPhosTAC. It induces dephosphorylation of EGFR at the pY1068 and pY845 sites, leading to apoptosis (Apoptosis) . AfaPhos1 exhibits anticancer activity against non-small cell lung cancer.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog